Antibody Production Market Size, Share, Industry Trends and Forecast to 2030

Antibody Production Market Size & CAGR in 2021

The global antibody production market had a market size of USD 10.5 billion in 2021 with a Compound Annual Growth Rate (CAGR) of 6% from 2020 to 2021.

COVID-19 Impact on the Antibody Production Market

The COVID-19 pandemic had a significant impact on the antibody production market. With the outbreak of the virus, there was a surge in demand for antibodies for diagnostic tests and vaccine development. This led to a boost in the market size and growth rate of the antibody production sector.

Antibody Production Dynamics

Antibody production plays a crucial role in the healthcare industry, especially in the development of diagnostics, therapeutics, and vaccines. The increasing prevalence of infectious diseases and the growing demand for personalized medicine have fueled the growth of the antibody production market.

Segments and Related Analysis

The antibody production market can be segmented based on type, application, end-user, and region. Different types of antibodies, such as monoclonal antibodies, polyclonal antibodies, and recombinant antibodies, cater to various applications like research, diagnostics, and therapeutics.

By Region Analysis

The antibody production market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest market share due to the presence of key market players, advanced healthcare infrastructure, and high R&D investments.

Key Market Players and Competitive Landscape

Some of the key players in the antibody production market include Thermo Fisher Scientific, Merck KGaA, Abcam plc, Cell Signaling Technology, and Bio-Rad Laboratories. These companies are actively involved in research and development to launch innovative antibody products and maintain their competitive position in the market.

Recent Happenings in the Antibody Production Market

- In September 2021, Thermo Fisher Scientific announced the acquisition of Mesa Biotech, a company specialized in molecular diagnostic tests based on polymerase chain reaction (PCR) technology. - In December 2021, Abcam plc collaborated with Yale University to develop novel antibodies for research applications. - In January 2022, Merck KGaA launched a new range of recombinant antibodies for cancer immunotherapy. - In March 2022, Bio-Rad Laboratories introduced a high-throughput platform for antibody screening and characterization.